Skip to Main Content
Pharmacist's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Opioid Resources
    • Transitions of Care Resources
    • Journal Club
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • NABP
    • Additional Requirements
    • Exemptions
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! RxAdvanced: Guide to Cannabis training for pharmacists that offers 16 hours of ACPE-accredited training based on the latest, science-based cannabis research. Only $199. Learn More!
  1. Home
  2. Browse
  3. Respiratory & Allergy
  4. Asthma
  5. Treatment

Treatment

  • Allergic Reactions (134)
  • Allergic Rhinitis (58)
  • Asthma (167)
    • Drug Interactions (6)
    • Immunizations (19)
    • Treatment (128)
  • Autoimmune Disorders (3)
  • COPD (144)
  • Cystic Fibrosis (4)
  • Ear Health (13)
  • Ear, Nose & Throat (37)
  • E-Cigarettes (1)
  • Immunology (5)
  • Inhalers (31)
  • Other (16)
  • Otolaryngology (22)
  • Pulmonary (24)
  • Resources (291)
  • Respiratory Infections (431)
  • Sleep Apnea (14)
  • Smoking (22)
  • Smoking Cessation (122)
76 - 90 of 128 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Other: FDA Podcast: Withdrawal of Primatene Mist (April 2011) November 2011
Article: You'll finally see Primatene Mist (epinephrine) disappear and the new Combivent Respimat appear November 2011
Commentary: Leukotriene Antagonists: A New Role in Asthma? July 2011
Article: Singulair is "as good as" inhaled corticosteroids or long-acting beta-agonists for asthma July 2011
Commentary: Corticosteroid-Induced Psychiatric Effects May 2011
Article: children getting inhaled corticosteroids PRN for MILD persistent asthma May 2011
Article: systemic corticosteroids can cause adverse CNS effects May 2011
Guideline: Canadian Thoracic Society Asthma Management Continuum – 2010 Consensus Summary for Children Six Years of Age and Over, and Adults November 2010
Commentary: Tiotropium (Spiriva) for Asthma November 2010
Guideline: Guidelines for the Diagnosis and Management of Asthma November 2010
Article: Spiriva (TIOtropium) used in some patients with asthma November 2010
Commentary: New Safety Requirements for Long-Acting Beta-Agonists (LABAs) April 2010
Guideline: NAEPP Guidelines for the Diagnosis and Management of Asthma – Summary Report 2007 April 2010
Commentary: Childhood Asthma Treatment: The BADGER Study April 2010
Commentary: Should Inhalers Be Stored Upright? April 2010
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved